Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Canine Cell Lines: Melanoma, Hemangiosarcoma and Osteosarcoma

Technology #20110168

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Collections
Image Gallery
Retrovirus Free Canine Cell LineCanine Cell Lines for Melanoma, Hemangiosarcoma and Osteosarcoma Research
Categories
Managed By
BJ Haun
Technology Licensing Officer

Canine Melanoma Cell Lines and Tissue Samples

Collection of three canine melanoma cell lines for research purposes. Melanoma is the most dangerous type of skin cancer, and is the leading cause of death from skin disease. Melanoma is not the most common form of skin cancer, but rates are steadily increasing. This cell line can be used as a research tool for cancer study, including; therapeutic development, mechanism studies, tumor ontology, surrogates for the human condition, etc.

MN-IP Try and Buy
MN-IP Try and Buy deal terms are in the process of being posted. Contact Rebecca Gerber for specific details.

PubMed ID# 9539362

Canine Hemangiosarcoma Cell Lines and Tissue Samples

Collection of over 17 canine hemangioma cell lines for research purposes. Hemangiosarcoma is a rapidly growing and very invasive form of cancer found in the lining of blood vessels. The most dangerous effect of this type of sarcoma is the rupturing of a vessel, causing the patient to bleed to death. This cell line can be used as a research tool for cancer study, including; therapeutic development, mechanism studies, tumor ontology, surrogates for the human condition, etc.

Canine Osteosarcoma Cell Lines and Tissue Samples

Collection of over 15 canine osteosarcoma cell lines for research purposes. Osteosarcoma is a malignant bone tumor that usually develops during the phase of rapid growth that occurs during adolescence. The cause of osteosarcoma is not yet known, but there is evidence showing that it may be genetically based. This cell line can be used as a research tool for cancer study, including; therapeutic development, mechanism studies, tumor ontology, surrogates for the human condition, etc. 
PubMed ID# 21621658